This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) dropped 0.66% to $7.50 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.95% to 4,395.64 and the Dow Jones Industrial Average rising 1.00% to 34,258.32. Ocugen Inc. closed $11.27 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. (ADVM) remained unchanged, Ocular Therapeutix Inc. (OCUL) rose 1.83% to $10.58, and Kodiak Sciences Inc. (KOD) rose 0.67% to $102.70. Trading volume (5.7 M) remained 7.8 million below its 50-day average volume of 13.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2021.
(END) Dow Jones Newswires
September 22, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.